Recruiting Interstitial Lung Disease Studies in New York
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Interstitial lung disease (ILD) is a lung condition resulting in inflammation and stiffening of the lung, often associated with connective tissue diseases (CTDs). ILD causes reduction in lung volume, ...
Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial
Effective, clinically meaningful treatments are lacking for patients with mild cognitive impairment (MCI), which is associated with increased risk of transition to dementia. Cognitive training represe...
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Ifetroban prevents and treats lung fibrosis due to multiple causes (bleomycin, genetic, radiation). The safety and efficacy of oral ifetroban will be assessed in patients with IPF....
Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
A Phase 3/4, Prospective, Randomized, Active Treatment-Controlled, Parallel-Design, Multicenter Study to Evaluate the Safety of DEXYCUfor the Treatment of Inflammation Following Ocular Surgery for Chi...
About Interstitial Lung Disease Clinical Trials in New York
Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.
There are currently 4 interstitial lung disease clinical trials recruiting participants in New York, NEW%20YORK. These studies are seeking a combined 868 participants. Research is being sponsored by GlaxoSmithKline, Columbia University, Cumberland Pharmaceuticals and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Interstitial Lung Disease Clinical Trials in New York — FAQ
Are there interstitial lung disease clinical trials in New York?
Yes, there are 4 interstitial lung disease clinical trials currently recruiting in New York, NEW%20YORK. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New York?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.
Are clinical trials in New York free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.
What interstitial lung disease treatments are being tested?
The 4 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial lung disease.
Data updated March 2, 2026 from ClinicalTrials.gov